E-pharma startups seek more clarity on data privacy

New Delhi: E-pharmacy players on Tuesday said they support the government’s draft e-Pharmacy policy but look forward to more clarity on the data privacy and data management.

Digital health platforms said they are in total support of the draft rules, as it would bring affordability and transparency for consumers, and would oppose the nation-wide strike called by the All India Organisation of Chemists and Druggists (AIOCD) on September 28, 2018.

“Few areas we would like additional clarity on

would be data privacy and data management,” said Prashant Tandon, co-founder, 1mg, on being asked about problems faced by the sector.

The online pharma players were speaking at a media briefing here.

Tandon further said: “There is a parallel Sri Krishna Committee for digital data, which is going on… We would prefer a clarity whether we have to comply with it.

Talking of the recent opposition to the government’s draft policy, the stakeholders said e-pharmacies would empower consumers and provide them multiple options to help them make an informed choice while buying their medicines.

  • Related Posts

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    Mumbai: Cancer patients and their caretakers in India often spend long, arduous hours in hospitals for conventional treatment. But now with the launch of the world’s first subcutaneous or under-the-skin…

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    New Delhi:  The Central Drugs Standard Control Organization (CDSCO) and state drug regulatory authorities have intensified drug safety crackdown as substandard and spurious medicine cases have risen during the last…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

    Kota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take Bodies

    Kota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take Bodies

    ICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026

    ICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026